DEPARIM£2n OF HEAL'IH HUMAN S£R\^CES 
PUBLIC HEALTH SEPVICE 
NATIONAL INSTITUTES OF HEALTH 
RECXMBINANT CNA ADVISORY COMMITTEE 
MINDTES OF MEETING! 
JANUARY 8-9, 1981 
The Reasnbinant CNA Advisory Camuttee (RAC) was convened for its twenty-first 
meeting at 9:00 a.m. on January 8, 1981, in Conference Room 10, Building 310, 
Nationed Institutes of Health, 9000 Roc^ille PiJce, Bethesda, Maryland 20205. 
Mr, Ray Thornton (Oiairman), President, Ariuuisas State University, presided. 
In accordance with I\jblic Law 92-463, the meeting was open to the public fron 
9:00 a.m. to 3:00 p.ro. on Jemuary 8, and from 9:00 a.m. to adjournment on 
Jamary 9. The meeting was closed to the public frcm 3:00 p.m. to 6:00 p.m. 
on January 8 for the review of proposals involving prx^ietary information. 
Conitiittee members present for all or part of the meeting were: 
Dr. Abdul Karim Ahmed; Dr. David Baltimore; Dr. Kenneth Bems; Dr. Winston Brill; 
Dr. Allan Canpbell; Mrs. Zelma Cason; Dr. Nina Fedoroff; Dr. Richard Goldstein; 
Dr. Susan Qotteaman; Dr. Jean Harris; Dr. King Holmes; Dr. Sheldon Krims)cy; 
Dt. Myron Levine; Dr. Wbmer Ma^ls; Dr. James Mason; Dr. Gerard McGarrity; 
Dr. Robert McKinney; Dr. Elena Nightingale; Dr. Ramon Pinon; Dr. John Scandalios; 
Dr. Luther Williars; and Dr. William J. Gartland, Jr., Executive Secretary. 
A Qonnittee roster is attached. (Attachment I) 
The following non-voting members and liaison representatives were present: 
Dr. Charlotte Bell, U. S. Department of Justice; Dr. Howard Berman, U. S. 
Veterans Mkninistration; Dr. Donald DeVincenzi, National Aeronautics and Space 
Administration; Dr. George Duda, U. S. Department of Ehergy; Dr. Timothy J. 
Henry, Food and Drug Administration; Dr. Herman Lewis, National Science Founda- 
tion; Dr. Chia T. Chen, (36HA, U. S. Department of Labor; Ck-. Sue Tblin, U. S. 
Department of Agriculture; and Dr. William J. Walsh, III, U. S. Department 
of State. 
!*Ihe RAC is advisory to the NIH, and its recommend at ions should not be 
considered as final and accepted. The Office of Recombinant DNA Activities 
should be consulted for NIH policy on specific issues. 
( 29 ) 
